These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 38279230)

  • 1. Multi-Omic Blood Biomarkers as Dynamic Risk Predictors in Late-Onset Alzheimer's Disease.
    Bhalala OG; Watson R; Yassi N
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive trajectory and proteomic signature of inherited risk for Alzheimer's disease.
    Paranjpe MD; Chaffin M; Zahid S; Ritchie S; Rotter JI; Rich SS; Gerszten R; Guo X; Heckbert S; Tracy R; Danesh J; Lander ES; Inouye M; Kathiresan S; Butterworth AS; Khera AV
    PLoS Genet; 2022 Sep; 18(9):e1010294. PubMed ID: 36048760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel biomarkers in Alzheimer's disease using high resolution proteomics and metabolomics: miRNAS, proteins and metabolites.
    Navas-Carrillo D; Rivera-Caravaca JM; Sampedro-Andrada A; Orenes-Piñero E
    Crit Rev Clin Lab Sci; 2021 May; 58(3):167-179. PubMed ID: 33137264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-omic prediction of incident type 2 diabetes.
    Carrasco-Zanini J; Pietzner M; Wheeler E; Kerrison ND; Langenberg C; Wareham NJ
    Diabetologia; 2024 Jan; 67(1):102-112. PubMed ID: 37889320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and multi-omic resources for Alzheimer disease and related dementia from the Knight Alzheimer Disease Research Center.
    Fernandez MV; Liu M; Beric A; Johnson M; Cetin A; Patel M; Budde J; Kohlfeld P; Bergmann K; Lowery J; Flynn A; Brock W; Sanchez Montejo B; Gentsch J; Sykora N; Norton J; Gentsch J; Valdez O; Gorijala P; Sanford J; Sun Y; Wang C; Western D; Timsina J; Mangetti Goncalves T; Do AN; Sung YJ; Zhao G; Morris JC; Moulder K; Holtzman DM; Bateman RJ; Karch C; Hassenstab J; Xiong C; Schindler SE; Balls-Berry JJ; Benzinger TLS; Perrin RJ; Denny A; Snider BJ; Stark SL; Ibanez L; Cruchaga C
    Sci Data; 2024 Jul; 11(1):768. PubMed ID: 38997326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polygenic risk score in postmortem diagnosed sporadic early-onset Alzheimer's disease.
    Chaudhury S; Patel T; Barber IS; Guetta-Baranes T; Brookes KJ; Chappell S; Turton J; Guerreiro R; Bras J; Hernandez D; Singleton A; Hardy J; Mann D; ; Morgan K
    Neurobiol Aging; 2018 Feb; 62():244.e1-244.e8. PubMed ID: 29103623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The critical need for defining preclinical biomarkers in Alzheimer's disease.
    Fiandaca MS; Mapstone ME; Cheema AK; Federoff HJ
    Alzheimers Dement; 2014 Jun; 10(3 Suppl):S196-212. PubMed ID: 24924671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omics-based biomarkers discovery for Alzheimer's disease.
    Aerqin Q; Wang ZT; Wu KM; He XY; Dong Q; Yu JT
    Cell Mol Life Sci; 2022 Nov; 79(12):585. PubMed ID: 36348101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease.
    Horgusluoglu E; Neff R; Song WM; Wang M; Wang Q; Arnold M; Krumsiek J; Galindo-Prieto B; Ming C; Nho K; Kastenmüller G; Han X; Baillie R; Zeng Q; Andrews S; Cheng H; Hao K; Goate A; Bennett DA; Saykin AJ; Kaddurah-Daouk R; Zhang B; ;
    Alzheimers Dement; 2022 Jun; 18(6):1260-1278. PubMed ID: 34757660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of Alzheimer's disease using multi-variants from a Chinese genome-wide association study.
    Jia L; Li F; Wei C; Zhu M; Qu Q; Qin W; Tang Y; Shen L; Wang Y; Shen L; Li H; Peng D; Tan L; Luo B; Guo Q; Tang M; Du Y; Zhang J; Zhang J; Lyu J; Li Y; Zhou A; Wang F; Chu C; Song H; Wu L; Zuo X; Han Y; Liang J; Wang Q; Jin H; Wang W; Lü Y; Li F; Zhou Y; Zhang W; Liao Z; Qiu Q; Li Y; Kong C; Li Y; Jiao H; Lu J; Jia J
    Brain; 2021 Apr; 144(3):924-937. PubMed ID: 33188687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common polygenic variation enhances risk prediction for Alzheimer's disease.
    Escott-Price V; Sims R; Bannister C; Harold D; Vronskaya M; Majounie E; Badarinarayan N; ; ; Morgan K; Passmore P; Holmes C; Powell J; Brayne C; Gill M; Mead S; Goate A; Cruchaga C; Lambert JC; van Duijn C; Maier W; Ramirez A; Holmans P; Jones L; Hardy J; Seshadri S; Schellenberg GD; Amouyel P; Williams J
    Brain; 2015 Dec; 138(Pt 12):3673-84. PubMed ID: 26490334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.
    Irwin DJ; Grossman M; Weintraub D; Hurtig HI; Duda JE; Xie SX; Lee EB; Van Deerlin VM; Lopez OL; Kofler JK; Nelson PT; Jicha GA; Woltjer R; Quinn JF; Kaye J; Leverenz JB; Tsuang D; Longfellow K; Yearout D; Kukull W; Keene CD; Montine TJ; Zabetian CP; Trojanowski JQ
    Lancet Neurol; 2017 Jan; 16(1):55-65. PubMed ID: 27979356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's polygenic risk scores, APOE, Alzheimer's disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over 17 years.
    Stocker H; Trares K; Beyer L; Perna L; Rujescu D; Holleczek B; Beyreuther K; Gerwert K; Schöttker B; Brenner H
    Alzheimers Res Ther; 2023 Jul; 15(1):129. PubMed ID: 37516890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omics-based Biomarkers for the Early Alzheimer Disease Diagnosis and Reliable Therapeutic Targets Development.
    Peña-Bautista C; Baquero M; Vento M; Cháfer-Pericás C
    Curr Neuropharmacol; 2019; 17(7):630-647. PubMed ID: 30255758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-omic atlas of the parahippocampal gyrus in Alzheimer's disease.
    Coleman C; Wang M; Wang E; Micallef C; Shao Z; Vicari JM; Li Y; Yu K; Cai D; Peng J; Haroutunian V; Fullard JF; Bendl J; Zhang B; Roussos P
    Sci Data; 2023 Sep; 10(1):602. PubMed ID: 37684260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic study of multimodal imaging Alzheimer's disease progression score implicates novel loci.
    Scelsi MA; Khan RR; Lorenzi M; Christopher L; Greicius MD; Schott JM; Ourselin S; Altmann A
    Brain; 2018 Jul; 141(7):2167-2180. PubMed ID: 29860282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting Complex and Multifactorial Nature of Alzheimer's Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective.
    Talwar P; Sinha J; Grover S; Rawat C; Kushwaha S; Agarwal R; Taneja V; Kukreti R
    Mol Neurobiol; 2016 Sep; 53(7):4833-64. PubMed ID: 26351077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-omics study to monitor senescence-associated secretory phenotypes of Alzheimer's disease.
    Yang J; Zhou Y; Wang T; Li N; Chao Y; Gao S; Zhang Q; Wu S; Zhao L; Dong X
    Ann Clin Transl Neurol; 2024 May; 11(5):1310-1324. PubMed ID: 38605603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multiomics approach to heterogeneity in Alzheimer's disease: focused review and roadmap.
    Badhwar A; McFall GP; Sapkota S; Black SE; Chertkow H; Duchesne S; Masellis M; Li L; Dixon RA; Bellec P
    Brain; 2020 May; 143(5):1315-1331. PubMed ID: 31891371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic diagnosis and prognosis of Alzheimer's disease: challenges and opportunities.
    Reitz C
    Expert Rev Mol Diagn; 2015 Mar; 15(3):339-48. PubMed ID: 25634383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.